Patient enrollment ongoing in phase I study of LBL-007 plus toripalimab in advanced melanoma March 1, 2021
Intrommune Therapeutics initiates phase I study of INT-301 in adults with peanut allergy March 1, 2021
IDMC recommends stopping enrollment of placebo group in phase III outpatient trial of REGEN-COV Feb. 26, 2021
RSS